To gather both qualitative and quantitative insights, supply-side and demand-side stakeholders were interviewed during the primary research phase. CEOs, VPs of cultivation operations, compliance officers, and heads of retail operations from licensed producers, medical cannabis dispensaries, and multi-state operators (MSOs) were examples of supply-side sources. Board-certified pain management experts, neurologists, oncologists, palliative care doctors, clinical pharmacists with expertise in cannabis therapy, and procurement leads from specialty clinics and hospital pharmacies were among the demand-side sources. In addition to confirming cultivation capacity expansion timelines and validating market segmentation across THC-dominant and CBD-dominant formulations, primary research also collected data on patient adherence trends, insurance reimbursement dynamics, physician prescribing patterns, and dosing standardization issues.
Primary Respondent Breakdown:
• By Designation: C-level Primaries (30%), Director Level (35%), Others (35%)
• By Region: North America (40%), Europe (25%), Asia-Pacific (28%), Rest of World (7%)
Global market valuation was derived through licensed producer revenue mapping and patient population analysis. The methodology included:
• Identification of 60+ licensed cultivators and processors across North America, Europe, Latin America, and Asia-Pacific
• Product mapping across dried flower, full-spectrum oils, isolates (THC/CBD), capsules, and topical formulations
• Analysis of reported and modeled revenues specific to medical cannabis portfolios, excluding adult-use/recreational segments
• Coverage of licensed producers and dispensary networks representing 65-70% of global medical market share in 2024
• Extrapolation using bottom-up (registered patient count × average monthly consumption × retail ASP by country) and top-down (licensed producer revenue validation) approaches to derive segment-specific valuations, adjusted for black market-to-legal conversion rates and prescription fulfillment gaps